• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Alvotech - Ordinary Shares (NQ:ALVO)

    8.190 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 159,583
    Open 8.150
    Bid (Size) 8.180 (4)
    Ask (Size) 8.190 (52)
    Prev. Close 8.190
    Today's Range 8.130 - 8.260
    52wk Range 7.350 - 13.70
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    This Johnson & Johnson Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
     
    Via Benzinga
    European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
    From Alvotech
    Via GlobeNewswire

    Performance

    YTD
    -37.8%
    -37.8%
    1 Month
    +3.0%
    +3.0%
    3 Month
    -9.7%
    -9.7%
    6 Month
    -15.0%
    -15.0%
    1 Year
    -31.2%
    -31.2%

    More News

    Read More
    European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner
    From Alvotech
    Via GlobeNewswire
    Alvotech's Earnings: A Preview
    Via Benzinga
    Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
    From Alvotech
    Via GlobeNewswire
    Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
    From Alvotech
    Via GlobeNewswire
    Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
    From Alvotech
    Via GlobeNewswire
    Soho House, GoodRx Holdings, Dayforce And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Alvotech SA (NASDAQ:ALVO) Surpasses Q2 2025 Estimates with Strong Revenue and EPS Growth
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Curious about the stocks that are showing activity after the closing bell on Wednesday?
    Via Chartmill
    Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
    From Alvotech
    Via GlobeNewswire
    Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
    From Alvotech
    Via GlobeNewswire
    Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
    From Alvotech
    Via GlobeNewswire
    Earnings Scheduled For August 13, 2025
    Via Benzinga
    Why Is Alvotech Stock Trading Higher On Wednesday?
    Via Benzinga
    Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
    From Alvotech
    Via GlobeNewswire
    Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
    From Alvotech
    Via GlobeNewswire
    Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
    From Alvotech
    Via GlobeNewswire
    Main Results of 2025 Annual and Extraordinary General Meeting
    From Alvotech
    Via GlobeNewswire
    Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
    From Alvotech
    Via GlobeNewswire
    European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
    From Alvotech
    Via GlobeNewswire
    Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
    From Alvotech
    Via GlobeNewswire
    Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
    From Alvotech
    Via GlobeNewswire
    Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
    Via Benzinga

    Frequently Asked Questions

    Is Alvotech - Ordinary Shares publicly traded?
    Yes, Alvotech - Ordinary Shares is publicly traded.
    What exchange does Alvotech - Ordinary Shares trade on?
    Alvotech - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Alvotech - Ordinary Shares?
    The ticker symbol for Alvotech - Ordinary Shares is ALVO on the Nasdaq Stock Market
    What is the current price of Alvotech - Ordinary Shares?
    The current price of Alvotech - Ordinary Shares is 8.190
    When was Alvotech - Ordinary Shares last traded?
    The last trade of Alvotech - Ordinary Shares was at 10/01/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.